Prepectoral Versus Subpectoral Implant-Based Breast Reconstruction: A Meta-analysis.
Yunzhu Li, Gang Xu, Nanze Yu...
https://pubmed.ncbi.nlm.nih.gov/31913902/Actively Recruiting
Led by Henan Cancer Hospital · Updated on 2025-06-25
104
Participants Needed
1
Research Sites
52 weeks
Total Duration
This research aims to evaluate the effectiveness and safety of two types of breast reconstruction in women with breast cancer who need postoperative radiotherapy. It focuses on comparing immediate one-stage prepectoral prosthetic reconstruction with two-stage expanderprosthesis reconstruction in patients diagnosed with breast cancer without distant metastasis. The study will record changes in quality of life using BREAST-Q scores, as well as complications, capsular contracture, and tumor safety over time. Participants will undergo nipple-sparing or skin-sparing mastectomy followed by either immediate prepectoral implant reconstruction or two-stage reconstruction involving a tissue expander first, then permanent implant after radiotherapy. Both surgical approaches allow open, endoscopic, or robotic techniques, with or without mesh use. Radiotherapy timing differs immediate reconstruction patients receive radiotherapy after implant placement, while two-stage reconstruction patients receive radiotherapy with the expander in place before implant exchange six or more months later. Throughout the study, patients will be monitored with quality of life assessments before surgery and one year afterward using BREAST-Q scores. Secondary outcomes include breast reconstruction success rates, surgical complications, aesthetic evaluations by doctors, capsular contracture development, nipple and skin sensation, and long-term tumor safety measured by disease-free and overall survival up to five years. The study plans to enroll over 104 patients, with participation lasting at least one year for primary outcomes and longer for survival follow-up.
CONDITIONS
Efficacy and Safety of Prepectoral Prosthesis Immediate One-Stage Breast Reconstruction Versus Two-Stage Expander/Prosthesis Reconstruction in Postoperative Adjuvant Radiotherapy Breast Cancer Patients: A Prospective, Single-Center, Cohort Study
X
xiuchun Chen
M
minhao Lv
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Henan Cancer Hospital
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Surgery and postoperative radiotherapy period
Participants undergo immediate one-stage prepectoral prosthetic breast reconstruction or two-stage expander/implant breast reconstruction with postoperative adjuvant radiotherapy.
Visits depending on surgical and radiotherapy schedules
Duration - Up to 1 year after surgery for primary and secondary outcomes; oncological safety assessed up to 5 years postoperatively
Participants are followed to assess breast reconstruction outcomes including BREAST-Q scores, complications, aesthetic effects, capsular contracture, nipple and skin sensation, and oncological safety.
Regular visits up to 1 year and long-term monitoring up to 5 years
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Yunzhu Li, Gang Xu, Nanze Yu...
https://pubmed.ncbi.nlm.nih.gov/31913902/Mark W Clemens, Steven J Kronowitz
https://pubmed.ncbi.nlm.nih.gov/23096982/Steven Sigalove
https://pubmed.ncbi.nlm.nih.gov/30842930/Sophocles H Voineskos, Jonas A Nelson, Anne F Klassen...
https://pubmed.ncbi.nlm.nih.gov/29414263/Steven J Kronowitz, Kelly K Hunt, Henry M Kuerer...
https://pubmed.ncbi.nlm.nih.gov/15114121/Allen Gabriel, G Patrick Maxwell
https://pubmed.ncbi.nlm.nih.gov/29166343/Stefan J Cano, Anne F Klassen, Amie M Scott...
https://pubmed.ncbi.nlm.nih.gov/22286412/Abhishek Chatterjee, Maurice Y Nahabedian, Allen Gabriel...
https://pubmed.ncbi.nlm.nih.gov/29346711/Hani Sbitany, Clara Gomez-Sanchez, Merisa Piper...
https://pubmed.ncbi.nlm.nih.gov/30589770/Sharat Chopra, Zaid Al-Ishaq, Raghavan Vidya
https://pubmed.ncbi.nlm.nih.gov/34307092/Henan Cancer Hospital
Lead Sponsor